Milestone Pharmaceuticals Inc. - Common Shares (NQ:MIST)
0.8001
-0.0799
(-9.08%)
Streaming Delayed Price
Updated: 2:19 PM EDT, Mar 31, 2025
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Milestone Pharmaceuticals: Q4 Earnings Insights
March 21, 2024
Why Milestone Pharmaceuticals (MIST) Stock Is Rising
February 26, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
March 28, 2025
Top movers in Friday's pre-market session
March 28, 2025
Why Is Milestone Pharmaceuticals Stock Plunging Today?
March 28, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 28, 2025
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 29, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
February 26, 2024
Frequently Asked QuestionsIs Milestone Pharmaceuticals Inc. - Common Shares publicly traded?
Yes, Milestone Pharmaceuticals Inc. - Common Shares is publicly traded.
What exchange does Milestone Pharmaceuticals Inc. - Common Shares trade on?
Milestone Pharmaceuticals Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Milestone Pharmaceuticals Inc. - Common Shares?
The ticker symbol for Milestone Pharmaceuticals Inc. - Common Shares is MIST on the Nasdaq Stock Market
What is the current price of Milestone Pharmaceuticals Inc. - Common Shares?
The current price of Milestone Pharmaceuticals Inc. - Common Shares is 0.8001
When was Milestone Pharmaceuticals Inc. - Common Shares last traded?
The last trade of Milestone Pharmaceuticals Inc. - Common Shares was at 03/31/25 02:19 PM ET
What is the market capitalization of Milestone Pharmaceuticals Inc. - Common Shares?
The market capitalization of Milestone Pharmaceuticals Inc. - Common Shares is 42.69M
How many shares of Milestone Pharmaceuticals Inc. - Common Shares are outstanding?
Milestone Pharmaceuticals Inc. - Common Shares has 43M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|